Unlocking the Potential of DNAJB7 (HSC3) as a Drug Target and Biomarker

Target Name: DNAJB7

NCBI ID: G150353

DNAJB7

Unlocking the Potential of DNAJB7 (HSC3) as a Drug Target and Biomarker

Introduction

DNAJB7 (histone switch complex subunit 7) is a non-coding RNA molecule that plays a critical role in the regulation of gene expression and DNA replication. HSC3, a specific DNAJB7 protein, has been identified as a potential drug target and biomarker for various diseases , including cancer, neurodegenerative disorders, and autoimmune diseases. In this article, we will explore the biology of DNAJB7 and its potential as a drug target and biomarker.

The Biology of DNAJB7

DNAJB7 is a member of the histone-switching complex (HSC), which is a protein-protein interaction network that plays a central role in the regulation of gene expression and DNA replication. The HSC consists of several subunits, including DNAJB1, DNAJB2, DNAJB6 , and DNAJB7, which are involved in the distinct stages of the DNA replication process.

DNAJB7 is a 22-kDa protein that contains 115 amino acid residues. It is composed of a N-terminal domain, a central transmembrane region, and a C-terminal domain. The N-terminal domain contains a unique ATP-binding site and a Conserved domain that is involved in the interaction with histone proteins. The central transmembrane region contains a variety of conserved ion channels, including a zinc ion channel and a potassium ion channel, which are involved in the regulation of intracellular signaling pathways. The C-terminal domain contains a conserved glycine residue that is involved in the formation of a disulfide bond, which is a hallmark of the G protein-coupled receptor (GPCR) family.

DNAJB7 has been shown to play a critical role in the regulation of gene expression and DNA replication. In various cellular contexts, DNAJB7 has been shown to interact with a variety of proteins, including histones, transcription factors, and DNA-protein binding proteins. For For example, DNAJB7 has been shown to interact with the histone protein histone H10 and the DNA-protein binding protein p21.

In addition to its role in the regulation of gene expression and DNA replication, DNAJB7 has also been shown to play a critical role in the development and progression of various diseases. For example, DNAJB7 has been shown to be overexpressed in various cancer tissues and to play a negative role in the regulation of cell proliferation. Additionally, DNAJB7 has been shown to be involved in the regulation of neurodegenerative disorders, including Alzheimer's disease and Parkinson's disease.

Potential Drug Target and Biomarker

The potential of DNAJB7 as a drug target and biomarker has been evaluated in various studies. One of the main advantages of DNAJB7 as a drug target is its unique structure and the variety of cellular processes that it is involved in. DNAJB7 has been shown to interact with a variety of proteins, including histones, transcription factors, and DNA-protein binding proteins, which provides a diverse range of potential targets for small molecules.

In addition to its potential as a drug target, DNAJB7 has also been shown to be a potential biomarker for various diseases. For example, DNAJB7 has been shown to be overexpressed in various cancer tissues and to play a negative role in the regulation of cell proliferation . Additionally, DNAJB7 has been shown to be involved in the regulation of neurodegenerative disorders, including Alzheimer's disease and Parkinson's disease.

An Overview of DNAJB7-based Therapeutic Strategies

Several therapeutic strategies have been proposed to target DNAJB7 and its downstream targets. One of the main approaches is the use of small molecules, such as drugs that can modulate the activity of DNAJB7 or its downstream targets.

Another approach is the use of antibodies that can specifically target DNAJB7 and its downstream targets. This approach

Protein Name: DnaJ Heat Shock Protein Family (Hsp40) Member B7

Functions: Probably acts as a co-chaperone

The "DNAJB7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DNAJB7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets